Tag: plasmid dna manufacturing market forecast

  • Insights Into The Plasmid DNA Manufacturing Market’s Growth Potential 2024-2033

    Insights Into The Plasmid DNA Manufacturing Market’s Growth Potential 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Plasmid DNA Manufacturing Market from 2024 to 2033?
    The plasmid DNA manufacturing market has experienced exponential growth, projected to rise from $1.89 billion in 2023 to $2.34 billion in 2024, with a CAGR of 23.6%. This growth is attributed to applications in genetic engineering, monoclonal antibody production, and environmental uses.

    The plasmid DNA manufacturing market is set for exponential growth, expected to reach $5.49 billion in 2028 at a CAGR of 23.7%. Growth factors include the rising use of plasmid DNA for DNA vaccines, increased adoption in developing antibody-drug conjugates, personalized therapies, cancer treatment development, and intellectual property advancements. Major trends include increased licensing agreements for plasmid DNA technologies, customized solutions, cost reduction strategies, high-throughput screening, and scalable manufacturing solutions.

    Claim Your Free Sample of the Global Plasmid DNA Manufacturing Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15895&type=smp

    What Key Factors Are Fueling the Growth of the Plasmid DNA Manufacturing Market?
    The growing acceptance of gene therapy is expected to propel the growth of the plasmid DNA manufacturing market going forward. Gene therapy refers to a medical treatment that involves modifying or manipulating a person’s genes to treat or prevent disease. Gene therapy is on the rise due to advancements in genetic engineering technologies, increased investment in research and development, successful clinical trials, and the growing prevalence of genetic disorders, which together highlight its potential for providing long-term or permanent cures. Plasmid DNA manufacturing is essential for gene therapy as it produces the vectors needed to deliver therapeutic genes into cells, facilitating the treatment of genetic disorders. For instance, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the number of gene therapies in Phase III clinical trials grew by 10% in Q3 2023, the first quarterly increase since Q3 2022. Therefore, the growing acceptance of gene therapy is driving the growth of the plasmid DNA manufacturing market.

    What Are the Major Segments of the Plasmid DNA Manufacturing Market?
    1) By Grade: Research And Development Grade, Good Manufacturing Practice (GMP) Grade
    2) By Development Phase: Pre-Clinical Therapeutics, Clinical Therapeutics, Marketed Therapeutics
    3) By Disease: Infectious Disease, Cancer, Genetic Disorder, Other Diseases
    4) By Application: Deoxyribonucleic Acid (DNA) Vaccines, Cell And Gene Therapy, Immunotherapy, Other Applications

    What New Trends Are Transforming the Plasmid DNA Manufacturing Market?
    Companies in the plasmid DNA manufacturing market are advancing bioprocessing technologies to improve efficiency and quality in plasmid DNA production. In January 2023, Charles River Laboratories launched the eXpDNA platform, integrating modern bioprocessing techniques to meet stringent regulatory standards for therapeutic applications.

    Order Now for Fast Delivery of Your Plasmid DNA Manufacturing Market Report!
    https://www.thebusinessresearchcompany.com/report/plasmid-dna-manufacturing-global-market-report

    Which Regions Are Driving Growth in the Plasmid DNA Manufacturing Market?
    North America was the largest region in the plasmid DNA manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasmid DNA manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Plasmid DNA Manufacturing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the plasmid dna manufacturing market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Plasmid DNA Manufacturing Market Include

    1. Plasmid DNA Manufacturing Market Executive Summary
    2. Plasmid DNA Manufacturing Market Segments
    3. Plasmid DNA Manufacturing Market Size And Template Market Growth Rate
    4.  Key Plasmid DNA Manufacturing Market Trends
    5. Major Plasmid DNA Manufacturing Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Plasmid DNA Manufacturing Market
    26. Top Plasmid DNA Manufacturing Companies
    27. Plasmid DNA Manufacturing Market Opportunities And Strategies
    28. Plasmid DNA Manufacturing Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Global Viral Vectors & Plasmid DNA Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

    DNA Repair Drugs Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/dna-repair-drugs-global-market-report

    DNA Sequencing Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How Is The Plasmid DNA Manufacturing Market Expected To Grow Through 2024-2033

    How Is The Plasmid DNA Manufacturing Market Expected To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Plasmid DNA Manufacturing Global Market Report 2024, the plasmid DNA manufacturing market is expected to show promising growth in the forecast period.

    Exponential Growth in Recent Years

    • Market Size Increase: The plasmid DNA manufacturing market has experienced significant growth, increasing from $1.89 billion in 2023 to $2.34 billion in 2024, marking a compound annual growth rate (CAGR) of 23.6%.
    • Key Drivers: Factors contributing to this growth include:
      • Application in industrial processes.
      • Use in genetically modified organisms.
      • Production of monoclonal antibodies.
      • International health initiatives.
      • Environmental applications like bioremediation.
      • Microbiome studies.

    Future Growth Projections

    • Continued Expansion: The market is projected to grow to $5.49 billion by 2028, with a CAGR of 23.7%.
    • Drivers of Future Growth:
      • Development of DNA vaccines for infectious diseases.
      • Adoption in antibody-drug conjugates and personalized therapies.
      • Use in cancer treatments.
      • Advancements in intellectual property.

    Trends Shaping the Market

    • Licensing Agreements: Increased activity in licensing agreements for plasmid DNA technologies.
    • Customized Solutions: Development of tailored solutions to meet specific needs.
    • Cost Reduction: Implementation of strategies to lower production costs.
    • High-Throughput Screening: Adoption of high-throughput screening methods.
    • Scalable Manufacturing: Creation of scalable manufacturing solutions.

    View More On The Plasmid DNA Manufacturing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/plasmid-dna-manufacturing-global-market-report

    Gene Therapy Driving Market Growth

    • Gene Therapy Boom: Growing acceptance of gene therapy, which modifies genes to treat or prevent diseases, is a significant market driver.
      • Advancements: Improvements in genetic engineering technologies and increased R&D investment.
      • Clinical Trials: Successful clinical trials and the rise in genetic disorders highlight the potential of gene therapy for long-term cures.
    • Plasmid DNA’s Role: Essential in producing vectors for gene therapy, facilitating genetic disorder treatments.
      • Clinical Trials Data: According to the American Society of Gene & Cell Therapy, the number of gene therapies in Phase III trials increased by 10% in Q3 2023.

    Leading Companies in the Market

    • Major Players: Key companies include Thermo Fisher Scientific Inc., Eurofins Genomics LLC, Catalent Inc., Charles River Laboratories, and Recipharm AB.
    • Other Notable Firms: Genscript Biotech Corporation, Aldevron LLC, Genewiz, OriGene Technologies, and Celonic AG.

    Innovations in Plasmid DNA Production

    • Advanced Bioprocessing Technologies: Companies are developing technologies to enhance efficiency, scalability, and quality.
      • Example: In January 2023, Charles River Laboratories launched the eXpDNA platform, integrating advanced technologies for high-quality plasmid DNA production.
      • Applications: Used in gene therapy, DNA vaccine development, and other biopharmaceutical applications requiring high yield, purity, and consistency.

    Strategic Acquisitions

    • Danaher Corporation and Aldevron: In August 2021, Danaher Corporation acquired Aldevron for $9.6 billion.
      • Impact: This acquisition enhances Danaher’s biotech capabilities, supporting the development of genetic treatments and advancing biotech research.

    Market Segmentation

    • By Grade:
      • Research and Development Grade
      • Good Manufacturing Practice (GMP) Grade
    • By Development Phase:
      • Pre-Clinical Therapeutics
      • Clinical Therapeutics
      • Marketed Therapeutics
    • By Disease:
      • Infectious Disease
      • Cancer
      • Genetic Disorder
      • Other Diseases
    • By Application:
      • DNA Vaccines
      • Cell and Gene Therapy
      • Immunotherapy
      • Other Applications

    Regional Insights

    • North America: Largest market in 2023.
    • Asia-Pacific: Expected to be the fastest-growing region during the forecast period.

    Request A Sample Of The Global Plasmid DNA Manufacturing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15895&type=smp